Quick Answer
ANAVEX LIFE SCIENCES CORP. reported Operating Income Loss of -$51.41 million for the year ending 2025.
- ANAVEX LIFE SCIENCES CORP. showed an increase of +2.8% in Operating Income Loss from 2024 to 2025.
- This data is from ANAVEX LIFE SCIENCES CORP.'s annual report (Form 10-K), filed with the SEC on November 25, 2025.
- XBRL data for this metric is available from 2010 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2010 to 2025), ANAVEX LIFE SCIENCES CORP.'s Operating Income Loss has declined by 810.2%.
- Historical annual values: Fiscal year 2025: -$51.41 million | Fiscal year 2024: -$52.88 million | Fiscal year 2023: -$55.76 million | Fiscal year 2022: -$50.99 million | Fiscal year 2021: -$42.00 million | Fiscal year 2020: -$31.09 million | Fiscal year 2014: -$2.97 million | Fiscal year 2013: -$2.14 million | Fiscal year 2012: -$4.32 million | Fiscal year 2011: -$6.18 million | Fiscal year 2010: -$5.65 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: